What evidence is there that Glucosaminchondroitin MSM can ameliorate symptoms of arthritis?

The short version: glucosamine, chondroitin, and MSM each show modest, inconsistent evidence for symptom relief in osteoarthritis, but the combination has not been proven clearly better than placebo.

The largest trial, the NIH-funded GAIT study, tested 1,583 people with knee osteoarthritis and found that the glucosamine-plus-chondroitin combination provided significant relief only for the subgroup with moderate-to-severe pain, while the overall result was inconclusive against placebo [1]. A 2025 systematic review of 146 studies (87 of them randomized trials) reported that most studies found some benefit for pain and function, but the authors noted the evidence is heterogeneous and limited, warranting cautious use [2]. Two 2018 meta-analyses came to slightly different conclusions: one found that glucosamine and chondroitin each reduced pain modestly compared to placebo, but their combination did not add benefit [3]; the other found chondroitin helped pain and function while glucosamine only helped stiffness [4]. A 2017 review in the British Journal of Sports Medicine was more dismissive, concluding that widely used supplements like glucosamine and chondroitin are not clinically effective [5].

The evidence for MSM is thinner. A 2025 Russian phase IV study tested a fixed combination of chondroitin, glucosamine, MSM, and hyaluronic acid in 60 patients with knee osteoarthritis flares. Both groups improved, but the group that also received collagen had greater pain reduction (74% vs 56% on VAS) and used fewer NSAIDs [7]. That study was open-label, small, and single-center, so it cannot be taken as strong proof. An animal study from 2025 used MSM as a positive control and found it reduced inflammatory markers in rats with induced osteoarthritis [13], but that is a long way from human benefit.

The evidence base is funded by a mix of public and industry sources, but most of the large trials and meta-analyses are not manufacturer-funded. The GAIT trial was NIH-funded [1]. The 2025 systematic review included studies from many countries and did not report industry funding as a dominant factor [2]. Still, the overall quality of evidence is low: effects are small, inconsistent across studies, and often fail to reach what clinicians consider a meaningful improvement. The supplements are generally safe, with mild gastrointestinal side effects being the most common [1, 2].

My call: glucosamine, chondroitin, and MSM may offer modest symptom relief for some people with osteoarthritis, but the evidence is too weak and inconsistent to recommend them with confidence. Confidence: low.